Completed NA INTERVENTIONAL 1-arm NCT01791062

Safety and Efficacy Study of HYTOP® in the Treatment of Focal Chondral Defects.

Safety and Efficacy of a Novel, Cell-free Cartilage Repair Construct in the Treatment of Focal Chondral Defects Involving the Femoro-tibial Compartment of the Knee Joint.

Sponsor: TRB Chemedica AG

Conditions Focal Chondral Defect in Femoro-tibial Compartment of the Knee Joint

Interventions HYTOP®

Updated 5 times since 2017 Last updated: Nov 18, 2016 Started: Feb 28, 2014 Primary completion: Oct 31, 2016 Completion: Oct 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01791062, this NA trial focuses on Focal Chondral Defect in Femoro-tibial Compartment of the Knee Joint and remains completed. Sponsored by TRB Chemedica AG, it has been updated 5 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

TRB Chemedica AG

Data source: TRB Chemedica AG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Osnabrück, Germany